Jones T - Search Results

1

Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?

Silva C, Ianna E, Jones T, Davis JS. Silva C, et al. Among authors: jones t. Hepatology. 2015 Aug;62(2):660-1. doi: 10.1002/hep.27601. Epub 2015 Jun 12. Hepatology. 2015. PMID: 25380552 No abstract available.

2

The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function.

Davis JS, Young M, Lennox S, Jones T, Piera K, Pickles R, Oakley S. Davis JS, et al. Among authors: jones t. Antivir Ther. 2018;23(8):687-694. doi: 10.3851/IMP3257. Antivir Ther. 2018. PMID: 30048244

3

The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.

Tran HA, Ianna EA, Jones TL, Reeves GE. Tran HA, et al. Among authors: jones tl. QJM. 2012 Jul;105(7):683-7. doi: 10.1093/qjmed/hcr094. Epub 2011 Jun 20. QJM. 2012. PMID: 21690180 No abstract available.

4

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study.

Tran HA, Jones TL, Ianna EA, Reeves GE. Tran HA, et al. Thyroid Res. 2011 Jan 8;4(1):2. doi: 10.1186/1756-6614-4-2. Thyroid Res. 2011. PMID: 21214950 Free PMC article.

5

Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective.

Tran HA, Jones TL, Ianna EA, Foy A, Reeves GE. Tran HA, et al. Endocr Pract. 2013 Mar-Apr;19(2):292-300. doi: 10.4158/EP12195.RA. Endocr Pract. 2013. PMID: 23186968 Free PMC article. Review.

6

Minimal Compared With Standard Monitoring During Sofosbuvir-Based Hepatitis C Treatment: A Randomized Controlled Trial.

Davis JS, Young M, Marshall C, Tate-Baker J, Madison M, Sharma S, Silva C, Jones T, Davies J. Davis JS, et al. Among authors: jones t. Open Forum Infect Dis. 2020 Jan 19;7(2):ofaa022. doi: 10.1093/ofid/ofaa022. eCollection 2020 Feb. Open Forum Infect Dis. 2020. PMID: 32083146 Free PMC article.

7

The reduced predictive value of interleukin 28b gene polymorphisms in a cohort of patients with thyroiditis developed during antiviral therapy for chronic hepatitis C: a preliminary study.

Tran HA, Jones TL, Ianna EA, Gibson RA, Reeves GE. Tran HA, et al. Hepat Mon. 2012 Aug;12(8):e6036. doi: 10.5812/hepatmon.6036. Epub 2012 Aug 30. Hepat Mon. 2012. PMID: 23087747 Free PMC article.

8

THE ABSENCE OF THYROID DISEASE IN AN AUSTRALIAN HEPATITIS C COHORT TREATED WITH TRIPLE COMBINATION THERAPY: A PARADIGM SHIFT.

Tran HA, Jones TL, Ianna EA, Reeves GE. Tran HA, et al. Endocr Pract. 2015 Sep;21(9):1035-9. doi: 10.4158/EP14561.OR. Epub 2015 Jun 29. Endocr Pract. 2015. PMID: 26121446

9

Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis.

Tran HA, Attia JR, Jones TL, Batey RG. Tran HA, et al. J Gastroenterol Hepatol. 2007 Apr;22(4):472-6. doi: 10.1111/j.1440-1746.2006.04771.x. J Gastroenterol Hepatol. 2007. PMID: 17376035

10

The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection.

Tran HA, Reeves GE, Jones TL. Tran HA, et al. Among authors: jones tl. QJM. 2009 Feb;102(2):117-22. doi: 10.1093/qjmed/hcn150. Epub 2008 Nov 25. QJM. 2009. PMID: 19033352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,077 results

Search Page

Filters